Cargando…

Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes

AIM: To evaluate the treatment effect Fand pharmacoeconomic value of Dugaglutide in women with type 2 diabetes. METHODS: Women (n=96) with type 2 diabetes recruited from June 2019 to December 2021 were randomized into two equal groups. The control group was treated with Liraglutide, and the observat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Yu, Zhang, Shuo, Wu, Zezhen, Liu, Weiting, Chen, Jingxian, Deng, Feiying, Chen, Fengwu, Zhu, Dan, Hou, Kaijian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9899911/ https://www.ncbi.nlm.nih.gov/pubmed/36755915 http://dx.doi.org/10.3389/fendo.2023.1054946

Ejemplares similares

Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review
por: Zhang, Shuo, et al.
Publicado: (2022)

Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial
por: Zhang, Shuo, et al.
Publicado: (2023)

The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019
por: Ye, Junjun, et al.
Publicado: (2023)

Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how
por: Hou, Kaijian, et al.
Publicado: (2022)

Metabolic remodeling of glycerophospholipids acts as a signature of dulaglutide and liraglutide treatment in recent-onset type 2 diabetes mellitus
por: Du, Juan, et al.
Publicado: (2023)

Vitamin D and Lipid Profiles in Postmenopausal Women: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
por: Liu, Weiting, et al.
Publicado: (2021)

Comparing Quality of Life in Type 2 Diabetic Patients Using Dulaglutide and Liraglutide
por: Ghosh, Aneesh
Publicado: (2021)

Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus
por: He, Lina, et al.
Publicado: (2022)

Bringing Liraglutide to Market: A CER Case Study
por: Oderda, Gary, et al.
Publicado: (2012)

Gut microbiota diversity in middle-aged and elderly patients with end-stage diabetic kidney disease
por: Chen, Rongping, et al.
Publicado: (2022)

Effects of dulaglutide combined with insulin degludec on glucose fluctuations and appetite in type 2 diabetes
por: Huang, Jinxin, et al.
Publicado: (2023)

Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study
por: Wu, Zezhen, et al.
Publicado: (2023)

Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
por: Kim, Youngsook, et al.
Publicado: (2022)

Polyethylene Glycol Loxenatide Injection (GLP-1) Protects Vascular Endothelial Cell Function in Middle-Aged and Elderly Patients With Type 2 Diabetes by Regulating Gut Microbiota
por: Chen, Fengwu, et al.
Publicado: (2022)

Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case Report
por: Dardano, Angela, et al.
Publicado: (2022)

Association between use of liraglutide and liver fibrosis in patients with type 2 diabetes
por: Tan, Yijiong, et al.
Publicado: (2022)

Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
por: Tanaka, Kenichi, et al.
Publicado: (2022)

Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial
por: Iijima, Takahiro, et al.
Publicado: (2023)

Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes
por: Wu, Hao, et al.
Publicado: (2023)

Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study
por: Kim, Hwi Seung, et al.
Publicado: (2022)

Efficacy and Safety of Dulaglutide Compared to Liraglutide: A Systematic Review and Meta-analysis in Patients with Type 2 Diabetes Mellitus
por: Taheri, Saeed, et al.
Publicado: (2019)

Corrigendum to Effects of switching from liraglutide to semaglutide or dulaglutide in patients with type 2 diabetes: A randomized controlled trial
Publicado: (2023)

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis
por: Chang, Kai-Cheng, et al.
Publicado: (2020)

Association between fasting blood glucose and thyroid stimulating hormones and suicidal tendency and disease severity in patients with major depressive disorder
por: Liu, Weiting, et al.
Publicado: (2022)

Liraglutide-Induced Weight Loss May be Affected by Autonomic Regulation in Type 1 Diabetes
por: Hansen, Christian Stevns, et al.
Publicado: (2019)

Gut Bacterial Characteristics of Patients With Type 2 Diabetes Mellitus and the Application Potential
por: Que, Yanyan, et al.
Publicado: (2021)

Effect of Dulaglutide Versus Liraglutide on Glucose Variability, Oxidative Stress, and Endothelial Function in Type 2 Diabetes: A Prospective Study
por: Nagaike, Hiroe, et al.
Publicado: (2019)

Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial
por: Takase, Takahiro, et al.
Publicado: (2018)

Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature
por: Xue, Yan, et al.
Publicado: (2023)

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics
por: García-Pérez, Luis-Emilio, et al.
Publicado: (2021)

The Discovery and Development of Liraglutide and Semaglutide
por: Knudsen, Lotte Bjerre, et al.
Publicado: (2019)

A Diabetic Patient Complicated With Pancreatic Cancer After Using Liraglutide: A Case Report
por: Wu, Shengjie, et al.
Publicado: (2021)

A Case of Dulaglutide-Induced Vaginal Bleed
por: Vaccaro, Christopher J, et al.
Publicado: (2023)

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
por: Boye, Kristina S., et al.
Publicado: (2020)

Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study
por: Jain, Akshay B., et al.
Publicado: (2020)

Effectiveness, Safety, and Patient Satisfaction of Liraglutide in Type 2 Diabetic Patients
por: Zameer, Rafia, et al.
Publicado: (2020)

Expert Opinion About the Pharmacoeconomic Edge of Low-Cost Dapagliflozin in Type 2 Diabetes Mellitus in Indian Clinical Settings
por: Sharma, Kamal, et al.
Publicado: (2021)

Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study
por: Ghosal, S., et al.
Publicado: (2018)

Symptoms of depression, perceived social support, and medical coping modes among middle-aged and elderly patients with type 2 diabetes
por: Zhang, Chuanyan, et al.
Publicado: (2023)

A Case Report of a Pregnant Woman With Type 2 Diabetes Mellitus Using Dulaglutide During the First Trimester of Pregnancy
por: Alghamdi, Adel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t6qb5bvja1urb0ehinemg24bku